2016 Q2/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +5 ProStrakan Group
7.5
2 -1 Neurocrine Biosciences
7.5
3 +0 Galenica AG
7.4
4 +1 Kyorin Holdings
7.1
5 +11 Yakult UK
7.1
6 +136 Biotecnol
7.1
7 +6 Bavarian Nordic
7.0
8 -6 Wockhardt
7.0
9 +0 MediGene
7.0
10 +85 Mitsubishi Tanabe
6.9
11 +0 Kaken Pharmaceutical
6.9
12 +0 Nissan Chemical
6.8
13 +9 Zandu
6.6
14 +62 Abbott Uk
6.5
15 +60 Abbott
6.5
16 -1 Meda Pharmaceuticals
6.4
17 +11 Baxter International
6.4
18 -14 Taisho Pharmaceutical
6.4
19 -11 Actelion
6.3
20 -13 Anika Therapeutics
6.2
21 +185 Julphar
6.2
22 -5 EISAI
6.2
23 +104 ARIAD Pharmaceuticals
6.1
24 -10 Mitsubishi Tanabe Pharma Europe Ltd
6.1
25 +36 Merz
6.0
26 +10 Diffusion Pharmaceuticals
5.9
27 +2 Pfizer UK
5.9
28 -7 Debiopharm
5.9
29 -6 Daiichi-Sankyo UK
5.8
30 +1 Forest
5.8
31 -12 EISAI UK
5.7
32 +72 Mochida
5.7
33 +1 CinnaGen
5.6
34 -4 Dainippon Sumitomo
5.5
35 +5 Recordati
5.4
36 +3 Covence
5.4
37 +48 Hospira
5.4
38 +19 Genzyme UK
5.4
39 +72 Bial Portela
5.4
40 +74 Asahi Kasei
5.3
41 -15 Sawai Pharmaceutical
5.3
42 +4 Nippon Chemiphar
5.3
43 +31 Agennix
5.2
44 -17 Enzo Biochem
5.2
45 +4 Biotest
5.2
46 -8 Takeda UK
5.2
47 -12 Astellas Europe
5.2
48 -7 Stallergenes UK
5.2
49 +14 Cipla
5.2
50 +47 Vitrolife
5.1


Changes in rank are compared to 2016 Q1/Global Life Sciences. Since then, 2 sites entered the survey, 1 site left the survey and 48 sites could not be included in the rankings (5 more since last time). Build your own. Report statistics.